| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.98▲ | 7.98▲ | 7.98▲ | 8.13▲ | 8.59▼ |
| MA10 | 8.20▲ | 8.20▲ | 8.20▲ | 8.04▲ | 8.37▼ |
| MA20 | 8.16▲ | 8.13▲ | 8.13▲ | 7.93▲ | 7.75▲ |
| MA50 | 8.73▼ | 8.04▲ | 7.88▲ | 8.08▲ | 8.87▼ |
| MA100 | 8.00▲ | 7.76▲ | 7.60▲ | 7.58▲ | 12.44▼ |
| MA200 | 7.48▲ | 7.11▲ | 7.21▲ | 8.51▼ | 29.70▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.027▼ | -0.038▼ | 0.048▲ | 0.213▲ |
| RSI | 50.589▲ | 51.991▲ | 52.515▲ | 54.635▲ | 49.968▼ |
| STOCH | 27.041 | 42.539 | 42.539 | 48.677 | 49.395 |
| WILL %R | -30.120 | -26.316 | -26.316 | -43.094 | -48.887 |
| CCI | 20.345 | 54.338 | 54.338 | 84.675 | 32.749 |
| CDL | $SNSE Doji Candlestick Pattern Detected | Set Alert |
|
Tuesday, August 05, 2025 09:47 PM
Sensei Biotherapeutics (NASDAQ:SNSE) is a clinical-stage immunotherapy company developing innovative antibody treatments for cancer. On August 5, 2025, it reported financial results for the second ...
|
|
Thursday, February 06, 2025 10:54 AM
Sensei Biotherapeutics (SNSE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
|
|
Wednesday, June 14, 2023 05:00 PM
Find the latest on short interest for Sensei Biotherapeutics, Inc. Common Stock (SNSE) at Nasdaq.com.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/08/25 | 8.355 | 8.355 | 8.355 | 8.355 | 0 |
| 28/08/25 | 8.33 | 8.69 | 8.33 | 8.355 | 4,928 |
| 27/08/25 | 7.6613 | 8.40 | 7.65 | 8.02 | 6,101 |
| 26/08/25 | 8.43 | 8.70 | 7.8323 | 7.8323 | 10,578 |
| 25/08/25 | 7.62 | 8.341 | 7.62 | 8.11 | 8,775 |
| 22/08/25 | 7.65 | 8.3619 | 7.65 | 7.96 | 10,826 |
| 21/08/25 | 8.2137 | 8.2137 | 7.49 | 7.5461 | 6,099 |
| 20/08/25 | 7.57 | 8.19 | 7.21 | 7.959 | 16,614 |
| 19/08/25 | 8.20 | 8.40 | 7.85 | 7.98 | 14,175 |
| 18/08/25 | 8.81 | 9.0559 | 8.27 | 8.27 | 37,848 |
|
|
||||
|
|
||||
|
|